Prevention of aortic calcification by etidronate in the renal failure rat model

European Journal of Pharmacology

Volumn 558, Issue 1-3, 2007, Pages 159-166

  Tamura, Kazuhiro ^a   Suzuki, Yusuke ^a   Matsushita, Mayumi ^a   Fujii, Hiroyuki ^a,b   Miyaura, Chisato ^c   Aizawa, Sumio ^d   Kogo, Hiroshi ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b TORANOMON HOSPITAL   (Japan)

^c TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^d Nakano Ekota Hospital   (Japan)

Author keywords

Etidronate; Hemodialysis; Matrix Gla protein; Renal failure; Vascular calcification

Indexed keywords

ALENDRONIC ACID; CALCITRIOL; CALCIUM; CREATININE; ETIDRONIC ACID; OSTEOCALCIN; PHOSPHORUS;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; AORTA DISEASE; ARTERY CALCIFICATION; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GENE EXPRESSION; KIDNEY FAILURE; MALE; NEPHRECTOMY; NONHUMAN; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RAT; THORACIC AORTA;

ANIMALS; AORTIC DISEASES; BONE DENSITY; CALCINOSIS; CALCIUM; CALCIUM-BINDING PROTEINS; DISEASE MODELS, ANIMAL; ETIDRONIC ACID; EXTRACELLULAR MATRIX PROTEINS; KIDNEY FAILURE; MALE; NEPHRECTOMY; OSTEOPONTIN; PARATHYROID HORMONE; PHOSPHORUS; RATS; RATS, WISTAR; RNA, MESSENGER; VASOCONSTRICTION;

EID: 33847275569     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.12.006     Document Type: Article

References (33)

1. Abedin M., Tintut Y., and Demer L.L. Vascular calcification: mechanisms and clinical ramifications. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1161-1170
2. Barengolts E.I., Berman M., Kukreja S.C., Kouznetsova T., Lin C., and Chomka E.V. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif. Tissue Int. 62 (1998) 209-213
3. Davies M.R., and Hruska K.A. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int. 60 (2001) 472-479
4. Dhore C.R., Cleutjens J.P., Lutgens E., Cleutjens K.B., Geusens P.P., Kitslaar P.J., Tordoir J.H., Spronk H.M., Vermeer C., and Daemen M.J. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1998-2003
5. Fleisch H. Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Drugs 42 (1991) 919-944
6. Goodman W.G., Goldin J., Kuizon B.D., Yoon C., Gales B., Sider D., Wang Y., Chung J., Emerick A., Greaser L., Elashoff R.M., and Salusky I.B. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N. Engl. J. Med. 342 (2000) 1478-1483
7. Hashiba H., Aizawa S., Tamura K., Shigematsu T., and Kogo H. Inhibitory effects of etidronate on the progression of vascular calcification in hemodialysis patients. Ther. Apher. Dial. 8 (2004) 241-247
8. Hashiba H., Aizawa S., Tamura K., and Kogo H. Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: long-term effects. Ther. Apher. Dial. 10 (2006) 59-65
9. 3. Nephrol. Dial. Transplant. 18 (2003) 1770-1776
10. Hruska K.A., Mathew S., and Saab G. Bone morphogenetic proteins in vascular calcification. Circ. Res. 97 (2005) 105-114
11. Jono S., Nishizawa Y., Shioi A., and Morii H. Parathyroid hormone-related peptide as a local regulator of vascular calcification. Its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 1135-1142
12. Jono S., McKee M.D., Murry C.E., Shioi A., Nishizawa Y., Mori K., Morii H., and Giachelli C.M. Phosphate regulation of vascular smooth muscle cell calcification. Circ. Res. 87 (2000) e10-e17
13. Jono S., Peinado C., and Giachelli C.M. Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J. Biol. Chem. 275 (2000) 20197-20203
14. Koshiyama H., Nakamura Y., Tanaka S., and Minamikawa J. Decrease in carotid Intima-media thickness after 1-year therapy with etidronate for osteopenia associated with type 2 diabetes. J. Clin. Endocrinol. Metab. 85 (2000) 2793-2796
15. Kramsch D.M., and Chan C.T. The effect of agents interfering with soft tissue calcification and cell proliferation on calcific fibrous-fatty plaques in rabbits. Circ. Res. 42 (1978) 562-571
16. Kramsch D.M., Aspen A.J., and Rozler L.J. Atherosclerosis: prevention by agents not affecting abnormal levels of blood lipids. Science 213 (1981) 1511-1512
17. London G.M., Guerin A.P., Marchais S.J., Metivier F., Pannier B., and Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol. Dial. Transplant. 18 (2003) 1731-1740
18. Luo G., Ducy P., McKee M.D., Pinero G.J., Loyer E., Behringer R.R., and Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix Gla protein. Nature 86 (1997) 78-81
19. Miyaura C., Kusano K., Masuzawa T., Chaki O., Onoe Y., Aoyagi M., Sasaki T., Tamura T., Koishihara Y., Ohsugi Y., et al. Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6. J. Bone Miner. Res. 10 (1995) 1365-1373
20. Mori K., Shioi A., Jono S., Nishizawa Y., and Morii H. Expression of matrix Gla protein (MGP) in an in vitro model of vascular calcification. FEBS Lett. 433 (1998) 19-22
21. Pohle K., Maffert R., Ropers D., Moshage W., Stilianakis N., Daniel W.G., and Achenbach S. Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation 104 (2001) 1927-1932
22. Price P.A., Urist M.R., and Otawara Y. Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem. Biophys. Res. Commun. 117 (1983) 765-771
23. Price P.A., Faus S.A., and Williamson M.K. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 817-824
24. Raggi P., Boulay A., Chasan-Taber S., Amin N., Dillon M., Burke S.K., and Chertow G.M. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?. J. Am. Coll. Cardiol. 39 (2002) 695-701
25. Rosenblum I.Y., Flora L., and Eisenstein R. The effect of disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP) on a rabbit model of athero-arteriosclerosis. Atherosclerosis 22 (1975) 411-424
26. Schenk R., Merz W.A., Muhlbauer R., Russell R.G., and Fleisch H. Effect of ethane-1-hydroxy-1, 1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl 2MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif. Tissue Res. 11 (1973) 196-214
27. Shao J.S., Cheng S.L., Charlton-Kachigian N., Loewy A.P., and Towler D.A. Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice. J. Biol. Chem. 278 (2003) 50195-50202
28. Shioi A., Taniwaki H., Jono S., Okuno Y., Koyama H., Mori K., and Nishizawa Y. Mönckeberg's medial sclerosis and inorganic phosphate in uremia. Am. J. Kidney Dis. 38 (2001) S47-S49
29. Szweras M., Liu D., Partridge E.A., Pawling J., Sukhu B., Clokie C., Jahnen-Dechent W., Tenenbaum H.C., Swallow C.J., Grynpas M.D., and Dennis J.W. Alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J. Biol. Chem. 277 (2002) 19991-19997
30. Tamura K., Hara T., Yoshie M., Irie S., Sobel A., and Kogo H. Enhanced expression of uterine stathmin during the process of implantation and decidualization in rats. Endocrinology 144 (2003) 1464-1473
31. Tamura K., Suzuki Y., Hashiba H., Tamura H., Aizawa S., and Kogo H. Effect of etidronate on aortic calcification and bone metabolism in calcitoriol-treated rats with subtotal nephrectomy. J. Pharmacol. Sci. 99 (2005) 89-94
32. Watson K.E., Bostrom K., Ravindranath R., Lam T., Norton B., and Demer L.L. TGF-beta1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J. Clin. Invest. 93 (1994) 2106-2113
33. Zebboudj A.F., Imura M., and Bostrom K. Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J. Biol. Chem. 277 (2002) 4388-4394